177 related articles for article (PubMed ID: 10590398)
1. Teratology Society Public Affairs Committee position paper: developmental toxicity of endocrine disruptors to humans.
Barlow S; Kavlock RJ; Moore JA; Schantz SL; Sheehan DM; Shuey DL; Lary JM
Teratology; 1999 Dec; 60(6):365-75. PubMed ID: 10590398
[No Abstract] [Full Text] [Related]
2. Statement of the Public Affairs Committee of the Teratology Society on the importance of smoking cessation during pregnancy.
Adams J
Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):895-9. PubMed ID: 14745924
[No Abstract] [Full Text] [Related]
3. [Endocrine disruptor compounds and their role in the developmental programming of the reproductive axis].
Guzmán C; Zambrano E
Rev Invest Clin; 2007; 59(1):73-81. PubMed ID: 17569302
[TBL] [Abstract][Full Text] [Related]
4. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
Public Affairs Committee of the Teratology Society
Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
[No Abstract] [Full Text] [Related]
5. Safety of first trimester exposure to H2 blockers.
Lagace E
J Fam Pract; 1996 Oct; 43(4):342-3. PubMed ID: 8874364
[No Abstract] [Full Text] [Related]
6. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
Brent RL
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
[TBL] [Abstract][Full Text] [Related]
7. Teratology Public Affairs Committee position paper: maternal obesity and pregnancy.
Scialli AR;
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):73-7. PubMed ID: 16463272
[TBL] [Abstract][Full Text] [Related]
8. [Wilson's principles--a base of modern teratology].
Burdan F; Bełzek A; Szumiło J; Dudka J; Korobowicz A; Tokarska E; Klepacz L; Bełzek M; Klepacz R
Pol Merkur Lekarski; 2006 Mar; 20(117):358-61. PubMed ID: 16780275
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
10. Diethylstilboestrol--effects of exposure in utero.
Drug Ther Bull; 1991 Jun; 29(13):49-50. PubMed ID: 1935586
[No Abstract] [Full Text] [Related]
11. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
[TBL] [Abstract][Full Text] [Related]
12. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
[TBL] [Abstract][Full Text] [Related]
13. [Diethylstilbestrol. Tragic late effect after prenatal exposure].
Forsberg JG
Lakartidningen; 1993 Apr; 90(15):1470, 1473-6. PubMed ID: 8479275
[No Abstract] [Full Text] [Related]
14. Statement of the Public Affairs Committee of the Teratology Society on the fetal alcohol syndrome.
Adams J; Bittner P; Buttar HS; Chambers CD; Collins TF; Daston GP; Filkins K; Flynn TJ; Graham JM; Lyons Jones K; Kimmel C; Lammer E; Librizzi R; Mitala J; Polifka JE
Teratology; 2002 Dec; 66(6):344-7. PubMed ID: 12486768
[No Abstract] [Full Text] [Related]
15. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression and teratology: evolving guidelines.
Armenti VT
J Am Soc Nephrol; 2004 Oct; 15(10):2759-60. PubMed ID: 15466283
[No Abstract] [Full Text] [Related]
17. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
Schaefer C; Hannemann D; Meister R
Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
[TBL] [Abstract][Full Text] [Related]
18. Selection bias in Teratology Information Service pregnancy outcome studies.
Johnson KA; Weber PA; Jones KL; Chambers CD
Teratology; 2001 Aug; 64(2):79-82. PubMed ID: 11460258
[TBL] [Abstract][Full Text] [Related]
19. Reliability of maternal reporting in identifying major congenital malformations.
Freedman B; Koren G
Vet Hum Toxicol; 2002 Jun; 44(3):180-1. PubMed ID: 12046978
[TBL] [Abstract][Full Text] [Related]
20. Teratology Society position paper: recommendations for vitamin A use during pregnancy.
Teratology; 1987 Apr; 35(2):269-75. PubMed ID: 3603408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
